Pluronics and MDR reversal: An update

Molecular Pharmaceutics

Volumn 11, Issue 8, 2014, Pages 2566-2578

  Alakhova, Daria Y ^a   Kabanov, Alexander V ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

cancer drug resistance; cancer stem cells; lipid rafts; mitochondria; Pgp; plasma membrane; Pluronic

Indexed keywords

ABC TRANSPORTER; COPOLYMER; DOXORUBICIN; LIPID; MACROGOL; MULTIDRUG RESISTANCE PROTEIN; PACLITAXEL; POLOXAMER; POLY(PROPYLENE OXIDE); UNCLASSIFIED DRUG; MACROGOL DERIVATIVE; PEO-PPO-PEO; PROPANEDIOL DERIVATIVE;

APOPTOSIS; CANCER CELL; CANCER STEM CELL; CELL MEMBRANE; CELL METABOLISM; CHEMOSENSITIZATION; CLINICAL STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; GENE EXPRESSION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID MEMBRANE; MITOCHONDRION; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CHEMISTRY; CYTOLOGY; DRUG RESISTANCE; METABOLISM; NEOPLASMS; TRANSPORT AT THE CELLULAR LEVEL; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; BIOLOGICAL TRANSPORT; CELL LINE, TUMOR; CELL MEMBRANE; DRUG DELIVERY SYSTEMS; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; HUMANS; LIPIDS; MEMBRANE MICRODOMAINS; MITOCHONDRIA; NEOPLASMS; NEOPLASTIC STEM CELLS; P-GLYCOPROTEIN; POLOXAMER; POLYETHYLENE GLYCOLS; PROPYLENE GLYCOLS;

EID: 84905454394     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp500298q     Document Type: Review

References (134)

1. Juliano, R. L.; Ling, V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants Biochim. Biophys. Acta 1976, 455, 152-162
2. Minko, T.; Rodriguez-Rodriguez, L.; Pozharov, V. Nanotechnology approaches for personalized treatment of multidrug resistant cancers Adv. Drug Delivery Rev. 2013, 65 (13-14) 1880-1895
3. Gao, Z.; Zhang, L.; Sun, Y. Nanotechnology applied to overcome tumor drug resistance J. Controlled Release 2012, 162, 45-55
4. Shapira, A.; Livney, Y. D.; Broxterman, H. J.; Assaraf, Y. G. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance Drug Resist. Updates 2011, 14, 150-163
5. Nieto Montesinos, R.; Beduneau, A.; Pellequer, Y.; Lamprecht, A. Delivery of P-glycoprotein substrates using chemosensitizers and nanotechnology for selective and efficient therapeutic outcomes J. Controlled Release 2012, 161, 50-61
6. Kunjachan, S.; Rychlik, B.; Storm, G.; Kiessling, F.; Lammers, T. Multidrug resistance: Physiological principles and nanomedical solutions Adv. Drug Delivery Rev. 2013, 65 (13-14) 1852-1865
7. Gottesman, M. M.; Fojo, T.; Bates, S. E. Multidrug resistance in cancer: role of ATP-dependent transporters Nat. Rev. Cancer 2002, 2, 48-58
8. Thomas, H.; Coley, H. M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting p-glycoprotein Cancer Control 2003, 10, 159-165
9. Liscovitch, M.; Lavie, Y. Cancer multidrug resistance: a review of recent drug discovery research IDrugs 2002, 5, 349-355
10. Ghetie, M. A.; Ghetie, V.; Vitetta, E. S. Anti-CD19 antibodies inhibit the function of the P-gp pump in multidrug-resistant B lymphoma cells Clin. Cancer Res. 1999, 5, 3920-3927
11. Amin, M. L. P-glycoprotein Inhibition for Optimal Drug Delivery Drug Target Insights 2013, 7, 27-34
12. Haus-Cohen, M.; Assaraf, Y. G.; Binyamin, L.; Benhar, I.; Reiter, Y. Disruption of P-glycoprotein anticancer drug efflux activity by a small recombinant single-chain Fv antibody fragment targeted to an extracellular epitope Int. J. Cancer 2004, 109, 750-758
13. Pakunlu, R. I.; Cook, T. J.; Minko, T. Simultaneous modulation of multidrug resistance and antiapoptotic cellular defense by MDR1 and BCL-2 targeted antisense oligonucleotides enhances the anticancer efficacy of doxorubicin Pharm. Res. 2003, 20, 351-359
14. Saad, M.; Garbuzenko, O. B.; Minko, T. Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer Nanomedicine 2008, 3, 761-776
15. Li, Y. T.; Chua, M. J.; Kunnath, A. P.; Chowdhury, E. H. Reversing multidrug resistance in breast cancer cells by silencing ABC transporter genes with nanoparticle-facilitated delivery of target siRNAs Int. J. Nanomed. 2012, 7, 2473-2481
16. Zhao, A.; Zeng, Q.; Xie, X.; Zhou, J.; Yue, W.; Li, Y.; Pei, X. MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression J. Genet. Genomics 2012, 39, 29-35
17. Wang, P.; Chen, J.; Mu, L. H.; Du, Q. H.; Niu, X. H.; Zhang, M. Y. Propofol inhibits invasion and enhances paclitaxel- induced apoptosis in ovarian cancer cells through the suppression of the transcription factor slug Eur. Rev. Med. Pharmacol. Sci. 2013, 17, 1722-1729
18. Hwang, K. E.; Park, D. S.; Kim, Y. S.; Kim, B. R.; Park, S. N.; Lee, M. K.; Park, S. H.; Yoon, K. H.; Jeong, E. T.; Kim, H. R. Prx1 modulates the chemosensitivity of lung cancer to docetaxel through suppression of FOXO1-induced apoptosis Int. J. Oncol. 2013, 43, 72-78
19. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Controlled Release 2000, 65, 271-284
20. Matsumura, Y.; Maeda, H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 1986, 46, 6387-6392
21. Alakhov, V.; Moskaleva, E.; Batrakova, E. V.; Kabanov, A. V. Hypersensitization of multidrug resistant human ovarian carcinoma cells by Pluronic P85 block copolymer Bioconjugate Chem. 1996, 7, 209-216
22. Alakhova, D. Y.; Zhao, Y.; Li, S.; Kabanov, A. V. Effect of doxorubicin/Pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia PLoS One 2013, 8, e72238
23. Batrakova, E. V.; Kabanov, A. V. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers J. Controlled Release 2008, 130, 98-106
24. Guan, Y.; Huang, J.; Zuo, L.; Xu, J.; Si, L.; Qiu, J.; Li, G. Effect of Pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism Arch. Pharm. Res. 2011, 34, 1719-1728
25. Hosseinzadeh, H.; Atyabi, F.; Dinarvand, R.; Ostad, S. N. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study Int. J. Nanomed. 2012, 7, 1851-1863
26. Krupka, T. M.; Exner, A. A. Structural parameters governing activity of Pluronic triblock copolymers in hyperthermia cancer therapy Int. J. Hyperthermia 2011, 27, 663-671
27. Li, G. C.; Mak, J. Y. Re-induction of hsp70 synthesis: an assay for thermotolerance. 1988 Int. J. Hyperthermia 2009, 25, 249-257
28. Perera, R. H.; Krupka, T. M.; Wu, H.; Traughber, B.; Dremann, D.; Broome, A. M.; Exner, A. A. Role of Pluronic block copolymers in modulation of heat shock protein 70 expression Int. J. Hyperthermia 2011, 27, 672-681
29. Zhao, Y.; Alakhova, D. Y.; Kabanov, A. V. Can nanomedicines kill cancer stem cells? Adv. Drug Delivery Rev. 2013, 65 (13-14) 1763-1783
30. Zhao, Y.; Alakhova, D. Y.; Kim, J. O.; Bronich, T. K.; Kabanov, A. V. A simple way to enhance Doxil(R) therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer J. Controlled Release 2013, 168, 61-69
31. Zaki, N. M. Augmented cytotoxicity of hydroxycamptothecin-loaded nanoparticles in lung and colon cancer cells by chemosensitizing pharmaceutical excipients Drug Delivery 2014, 21 (4) 265-275
32. Hong, W.; Chen, D.; Zhang, X.; Zeng, J.; Hu, H.; Zhao, X.; Qiao, M. Reversing multidrug resistance by intracellular delivery of Pluronic(R) P85 unimers Biomaterials 2013, 34, 9602-9614
33. Frisman, I.; Seliktar, D.; Bianco-Peled, H. Nanostructuring biosynthetic hydrogels for tissue engineering: a cellular and structural analysis Acta Biomater. 2012, 8, 51-60
34. Frisman, I.; Seliktar, D.; Bianco-Peled, H. Nanostructuring PEG-fibrinogen hydrogels to control cellular morphogenesis Biomaterials 2011, 32, 7839-7846
35. Cha, M. H.; Choi, J.; Choi, B. G.; Park, K.; Kim, I. H.; Jeong, B.; Han, D. K. Synthesis and characterization of novel thermo-responsive F68 block copolymers with cell-adhesive RGD peptide J. Colloid Interface Sci. 2011, 360, 78-85
36. Li, X.; Chen, D.; Le, C.; Zhu, C.; Gan, Y.; Hovgaard, L.; Yang, M. Novel mucus-penetrating liposomes as a potential oral drug delivery system: preparation, in vitro characterization, and enhanced cellular uptake Int. J. Nanomed. 2011, 6, 3151-3162
37. Alakhov, V.; Klinski, E.; Li, S.; Pietrzynski, G.; Venne, A.; Batrakova, E.; Bronitch, T.; Kabanov, A. V. Block copolymer-based formulation of doxorubicin. From cell screen to clinical trials Colloids Surf., B: Biointerfaces 1999, 16, 113-134
38. Alakhova, D. Y.; Rapoport, N. Y.; Batrakova, E. V.; Timoshin, A. A.; Li, S.; Nicholls, D.; Alakhov, V. Y.; Kabanov, A. V. Differential metabolic responses to Pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers J. Controlled Release 2010, 142, 89-100
39. Batrakova, E. V.; Li, S.; Elmquist, W. F.; Miller, D. W.; Alakhov, V. Y.; Kabanov, A. V. Mechanism of sensitization of MDR cancer cells by Pluronic block copolymers: Selective energy depletion Br. J. Cancer 2001, 85, 1987-1997
40. Batrakova, E. V.; Li, S.; Li, Y.; Alakhov, V. Y.; Kabanov, A. V. Effect of Pluronic P85 on ATPase activity of drug efflux transporters Pharm. Res. 2004, 21, 2226-2233
41. Batrakova, E. V.; Kelly, D. L.; Li, S.; Li, Y.; Yang, Z.; Xiao, L.; Alakhova, D. Y.; Sherman, S.; Alakhov, V. Y.; Kabanov, A. V. Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: Pluronic P85 Mol. Pharmaceutics 2006, 3, 113-123
42. Sharma, A. K.; Zhang, L.; Li, S.; Kelly, D. L.; Alakhov, V. Y.; Batrakova, E. V.; Kabanov, A. V. Prevention of MDR development in leukemia cells by micelle-forming polymeric surfactant J. Controlled Release 2008, 131, 220-227
43. Cole, S. P.; Bhardwaj, G.; Gerlach, J. H.; Mackie, J. E.; Grant, C. E.; Almquist, K. C.; Stewart, A. J.; Kurz, E. U.; Duncan, A. M.; Deeley, R. G. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line Science 1992, 258, 1650-1654
44. Didziapetris, R.; Japertas, P.; Avdeef, A.; Petrauskas, A. Classification analysis of P-glycoprotein substrate specificity J. Drug Targeting 2003, 11, 391-406
45. Doyle, L. A.; Yang, W.; Abruzzo, L. V.; Krogmann, T.; Gao, Y.; Rishi, A. K.; Ross, D. D. A multidrug resistance transporter from human MCF-7 breast cancer cells Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 15665-15670
46. Robey, R. W.; Polgar, O.; Deeken, J.; To, K. W.; Bates, S. E. ABCG2: determining its relevance in clinical drug resistance Cancer Metastasis Rev. 2007, 26, 39-57
47. Muller, M. B.; Keck, M. E.; Binder, E. B.; Kresse, A. E.; Hagemeyer, T. P.; Landgraf, R.; Holsboer, F.; Uhr, M. ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary- adrenocortical system: implications for affective disorder Neuropsychopharmacology 2003, 28, 1991-1999
48. Thiebaut, F.; Tsuruo, T.; Hamada, H.; Gottesman, M. M.; Pastan, I.; Willingham, M. C. Immunohistochemical localization in normal tissues of different epitopes in the multidrug transport protein P170: evidence for localization in brain capillaries and crossreactivity of one antibody with a muscle protein J. Histochem. Cytochem. 1989, 37, 159-164
49. Demeule, M.; Labelle, M.; Regina, A.; Berthelet, F.; Beliveau, R. Isolation of endothelial cells from brain, lung, and kidney: expression of the multidrug resistance P-glycoprotein isoforms Biochem. Biophys. Res. Commun. 2001, 281, 827-834
50. Devault, A.; Gros, P. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities Mol. Cell. Biol. 1990, 10, 1652-1663
51. Cordon-Cardo, C.; OBrien, J. P.; Casals, D.; Rittman-Grauer, L.; Biedler, J. L.; Melamed, M. R.; Bertino, J. R. Multidrug-resistance gene (P-glycoprotein) is expressed by endothelial cells at blood-brain barrier sites Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 695-698
52. Gatlik-Landwojtowicz, E.; Aanismaa, P.; Seelig, A. Quantification and characterization of P-glycoprotein-substrate interactions Biochemistry 2006, 45, 3020-3032
53. Sauna, Z. E.; Ambudkar, S. V. Characterization of the catalytic cycle of ATP hydrolysis by human P-glycoprotein. The two ATP hydrolysis events in a single catalytic cycle are kinetically similar but affect different functional outcomes J. Biol. Chem. 2001, 276, 11653-11661
54. Ramachandra, M.; Ambudkar, S. V.; Chen, D.; Hrycyna, C. A.; Dey, S.; Gottesman, M. M.; Pastan, I. Human P-glycoprotein exhibits reduced affinity for substrates during a catalytic transition state Biochemistry 1998, 37, 5010-5019
55. Al-Shawi, M. K.; Polar, M. K.; Omote, H.; Figler, R. A. Transition state analysis of the coupling of drug transport to ATP hydrolysis by P-glycoprotein J. Biol. Chem. 2003, 278, 52629-52640
56. Aller, S. G.; Yu, J.; Ward, A.; Weng, Y.; Chittaboina, S.; Zhuo, R.; Harrell, P. M.; Trinh, Y. T.; Zhang, Q.; Urbatsch, I. L.; Chang, G. Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding Science 2009, 323, 1718-1722
57. Batrakova, E. V.; Li, S.; Alakhov, V. Y.; Elmquist, W. F.; Miller, D. W.; Kabanov, A. V. Sensitization of cells overexpressing multidrug-resistant proteins by Pluronic P85 Pharm. Res. 2003, 20, 1581-1590
58. Yamagata, T.; Kusuhara, H.; Morishita, M.; Takayama, K.; Benameur, H.; Sugiyama, Y. Effect of excipients on breast cancer resistance protein substrate uptake activity J. Controlled Release 2007, 124, 1-5
59. Kabanov, A. V.; Batrakova, E. V.; Alakhov, V. Y. Pluronic block copolymers for overcoming drug resistance in cancer Adv. Drug Delivery Rev. 2002, 54, 759-779
60. Demina, T.; Grozdova, I.; Krylova, O.; Zhirnov, A.; Istratov, V.; Frey, H.; Kautz, H.; Melik-Nubarov, N. Relationship between the structure of amphiphilic copolymers and their ability to disturb lipid bilayers Biochemistry 2005, 44, 4042-4054
61. Marguet, D.; Lenne, P. F.; Rigneault, H.; He, H. T. Dynamics in the plasma membrane: how to combine fluidity and order EMBO J. 2006, 25, 3446-3457
62. Simons, K.; Ikonen, E. Functional rafts in cell membranes Nature 1997, 387, 569-572
63. Barakat, S.; Gayet, L.; Dayan, G.; Labialle, S.; Lazar, A.; Oleinikov, V.; Coleman, A. W.; Baggetto, L. G. Multidrug-resistant cancer cells contain two populations of P-glycoprotein with differently stimulated P-gp ATPase activities: evidence from atomic force microscopy and biochemical analysis Biochem. J. 2005, 388, 563-571
64. Ghetie, M. A.; Marches, R.; Kufert, S.; Vitetta, E. S. An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line Blood 2004, 104, 178-183
65. Troost, J.; Lindenmaier, H.; Haefeli, W. E.; Weiss, J. Modulation of cellular cholesterol alters P-glycoprotein activity in multidrug-resistant cells Mol. Pharmacol. 2004, 66, 1332-1339
66. Kamau, S. W.; Kramer, S. D.; Gunthert, M.; Wunderli-Allenspach, H. Effect of the modulation of the membrane lipid composition on the localization and function of P-glycoprotein in MDR1-MDCK cells In Vitro Cell. Dev. Biol.: Anim. 2005, 41, 207-216
67. Luker, G. D.; Pica, C. M.; Kumar, A. S.; Covey, D. F.; Piwnica-Worms, D. Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains Biochemistry 2000, 39, 7651-7661
68. Sharom, F. J. ABC multidrug transporters: structure, function and role in chemoresistance Pharmacogenomics 2008, 9, 105-127
69. Callaghan, R.; Berridge, G.; Ferry, D. R.; Higgins, C. F. The functional purification of P-glycoprotein is dependent on maintenance of a lipid-protein interface Biochim. Biophys. Acta 1997, 1328, 109-124
70. Romsicki, Y.; Sharom, F. J. The membrane lipid environment modulates drug interactions with the P-glycoprotein multidrug transporter Biochemistry 1999, 38, 6887-6896
71. Meyer dos Santos, S.; Weber, C. C.; Franke, C.; Muller, W. E.; Eckert, G. P. Cholesterol: Coupling between membrane microenvironment and ABC transporter activity Biochem. Biophys. Res. Commun. 2007, 354, 216-221
72. Cai, C.; Zhu, H.; Chen, J. Overexpression of caveolin-1 increases plasma membrane fluidity and reduces P-glycoprotein function in Hs578T/Dox Biochem. Biophys. Res. Commun. 2004, 320, 868-874
73. Melik-Nubarov, N. S.; Pomaz, O. O.; Dorodnych, T.; Badun, G. A.; Ksenofontov, A. L.; Schemchukova, O. B.; Arzhakov, S. A. Interaction of tumor and normal blood cells with ethylene oxide and propylene oxide block copolymers FEBS Lett. 1999, 446, 194-198
74. Gau-Racine, J.; Lal, J.; Zeghal, M.; Auvray, L. PEO-PPO block copolymer vectors do not interact directly with DNA but with lipid membranes J. Phys. Chem. B 2007, 111, 9900-9907
75. Ng, R.; Metzger, J. M.; Claflin, D. R.; Faulkner, J. A. Poloxamer 188 reduces the contraction-induced force decline in lumbrical muscles from mdx mice Am. J. Physiol. 2008, 295, C146-150
76. Wu, G.; Majewski, J.; Ege, C.; Kjaer, K.; Weygand, M. J.; Lee, K. Y. Interaction between lipid monolayers and poloxamer 188: an X-ray reflectivity and diffraction study Biophys. J. 2005, 89, 3159-3173
77. Krylova, O. O.; Melik-Nubarov, N. S.; Badun, G. A.; Ksenofontov, A. L.; Menger, F. M.; Yaroslavov, A. A. Pluronic L61 accelerates flip-flop and transbilayer doxorubicin permeation Chemistry 2003, 9, 3930-3936
78. Krylova, O. O.; Pohl, P. Ionophoric activity of Pluronic block copolymers Biochemistry 2004, 43, 3696-3703
79. Lee, R. C.; River, L. P.; Pan, F. S.; Ji, L.; Wollmann, R. L. Surfactant-induced sealing of electropermeabilized skeletal muscle membranes in vivo Proc. Natl. Acad. Sci. U.S.A. 1992, 89, 4524-4528
80. Padanilam, J. T.; Bischof, J. C.; Lee, R. C.; Cravalho, E. G.; Tompkins, R. G.; Yarmush, M. L.; Toner, M. Effectiveness of poloxamer 188 in arresting calcein leakage from thermally damaged isolated skeletal muscle cells Ann. N.Y. Acad. Sci. 1994, 720, 111-123
81. Hannig, J.; Zhang, D.; Canaday, D. J.; Beckett, M. A.; Astumian, R. D.; Weichselbaum, R. R.; Lee, R. C. Surfactant sealing of membranes permeabilized by ionizing radiation Radiat. Res. 2000, 154, 171-177
82. Cheng, C. Y.; Wang, J. Y.; Kausik, R.; Lee, K. Y.; Han, S. Nature of interactions between PEO-PPO-PEO triblock copolymers and lipid membranes: (II) role of hydration dynamics revealed by dynamic nuclear polarization Biomacromolecules 2012, 13, 2624-2633
83. Wang, J. Y.; Chin, J.; Marks, J. D.; Lee, K. Y. Effects of PEO-PPO-PEO triblock copolymers on phospholipid membrane integrity under osmotic stress Langmuir 2010, 26, 12953-12961
84. Nawaz, S.; Redhead, M.; Mantovani, G.; Alexander, C.; Bosquillon, C.; Carbone, P. Interactions of PEO-PPO-PEO block copolymers with lipid membranes: a computational and experimental study linking membrane lysis with polymer structure Soft Matter 2012, 8, 6744-6754
85. Rapoport, N.; Marin, A.; Luo, Y.; Prestwich, G. D.; Muniruzzaman, M. D. Intracellular uptake and trafficking of Pluronic micelles in drug-sensitive and MDR cells: effect on the intracellular drug localization J. Pharm. Sci. 2002, 91, 157-170
86. Ramu, A.; Glaubiger, D.; Magrath, I. T.; Joshi, A. Plasma membrane lipid structural order in doxorubicin-sensitive and -resistant P388 cells Cancer Res. 1983, 43, 5533-5537
87. Boutin, C.; Roche, Y.; Millot, C.; Deturche, R.; Royer, P.; Manfait, M.; Plain, J. M.; Jeannesson, P.; Millot, J. M.; Jaffiol, R. High heterogeneity of plasma membrane microfluidity in multidrug-resistant cancer cells J. Biomed. Opt. 2009, 14, 034030
88. Santini, M. T.; Romano, R.; Rainaldi, G.; Filippini, P.; Bravo, E.; Porcu, L.; Motta, A.; Calcabrini, A.; Meschini, S.; Indovina, P. L.; Arancia, G. The relationship between 1H-NMR mobile lipid intensity and cholesterol in two human tumor multidrug resistant cell lines (MCF-7 and LoVo) Biochim. Biophys. Acta 2001, 1531, 111-131
89. Le Moyec, L.; Tatoud, R.; Degeorges, A.; Calabresse, C.; Bauza, G.; Eugene, M.; Calvo, F. Proton nuclear magnetic resonance spectroscopy reveals cellular lipids involved in resistance to adriamycin and taxol by the K562 leukemia cell line Cancer Res. 1996, 56, 3461-3467
90. Zhirnov, A. E.; Demina, T. V.; Krylova, O. O.; Grozdova, I. D.; Melik-Nubarov, N. S. Lipid composition determines interaction of liposome membranes with Pluronic L61 Biochim. Biophys. Acta 2005, 1720, 73-83
91. Regev, R.; Assaraf, Y. G.; Eytan, G. D. Membrane fluidization by ether, other anesthetics, and certain agents abolishes P-glycoprotein ATPase activity and modulates efflux from multidrug-resistant cells Eur. J. Biochem. 1999, 259, 18-24
92. Sahay, G.; Gautam, V.; Luxenhofer, R.; Kabanov, A. V. The utilization of pathogen-like cellular trafficking by single chain block copolymer Biomaterials 2010, 31, 1757-1764
93. Batrakova, E. V.; Li, S.; Vinogradov, S. V.; Alakhov, V. Y.; Miller, D. W.; Kabanov, A. V. Mechanism of Pluronic effect on P-glycoprotein efflux system in blood-brain barrier: contributions of energy depletion and membrane fluidization J. Pharmacol. Exp. Ther. 2001, 299, 483-493
94. Warburg, O. On the origin of cancer cells Science 1956, 123, 309-314
95. Lyon, R. C.; Cohen, J. S.; Faustino, P. J.; Megnin, F.; Myers, C. E. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy Cancer Res. 1988, 48, 870-877
96. Miccadei, S.; Fanciulli, M.; Bruno, T.; Paggi, M. G.; Floridi, A. Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells Oncol. Res. 1996, 8, 27-35
97. Harper, M. E.; Antoniou, A.; Villalobos-Menuey, E.; Russo, A.; Trauger, R.; Vendemelio, M.; George, A.; Bartholomew, R.; Carlo, D.; Shaikh, A.; Kupperman, J.; Newell, E. W.; Bespalov, I. A.; Wallace, S. S.; Liu, Y.; Rogers, J. R.; Gibbs, G. L.; Leahy, J. L.; Camley, R. E.; Melamede, R.; Newell, M. K. Characterization of a novel metabolic strategy used by drug-resistant tumor cells FASEB J. 2002, 16, 1550-1557
98. Teplova, V. V.; Kudrjavtsev, A. A.; Odinokova, I. V.; Evtodienko, Y. V.; Saris, N. E. Effect of prooxidants on mitochondrial permeability transition and cell death in Ehrlich ascites tumour cells Biochem. Mol. Biol. Int. 1998, 45, 501-510
99. Batrakova, E. V.; Li, S.; Alakhov, V. Y.; Miller, D. W.; Kabanov, A. V. Optimal structure requirements for Pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells J. Pharmacol. Exp. Ther. 2003, 304, 845-854
100. Batrakova, E.; Lee, S.; Li, S.; Venne, A.; Alakhov, V.; Kabanov, A. Fundamental relationships between the composition of Pluronic block copolymers and their hypersensitization effect in MDR cancer cells Pharm. Res. 1999, 16, 1373-1379
101. Circu, M. L.; Aw, T. Y. Glutathione and apoptosis Free Radical Res. 2008, 42, 689-706
102. Susin, S. A.; Lorenzo, H. K.; Zamzami, N.; Marzo, I.; Snow, B. E.; Brothers, G. M.; Mangion, J.; Jacotot, E.; Costantini, P.; Loeffler, M.; Larochette, N.; Goodlett, D. R.; Aebersold, R.; Siderovski, D. P.; Penninger, J. M.; Kroemer, G. Molecular characterization of mitochondrial apoptosis-inducing factor Nature 1999, 397, 441-446
103. Li, L. Y.; Luo, X.; Wang, X. Endonuclease G is an apoptotic DNase when released from mitochondria Nature 2001, 412, 95-99
104. Minko, T.; Batrakova, E. V.; Li, S.; Li, Y.; Pakunlu, R. I.; Alakhov, V. Y.; Kabanov, A. V. Pluronic block copolymers alter apoptotic signal transduction of doxorubicin in drug-resistant cancer cells J. Controlled Release 2005, 105, 269-278
105. Batrakova, E. V.; Li, S.; Brynskikh, A. M.; Sharma, A. K.; Li, Y.; Boska, M.; Gong, N.; Mosley, R. L.; Alakhov, V. Y.; Gendelman, H. E.; Kabanov, A. V. Effects of Pluronic and doxorubicin on drug uptake, cellular metabolism, apoptosis and tumor inhibition in animal models of MDR cancers J. Controlled Release 2010, 143, 290-301
106. Doroshow, J. H. Prevention of doxorubicin-induced killing of MCF-7 human breast cancer cells by oxygen radical scavengers and iron chelating agents Biochem. Biophys. Res. Commun. 1986, 135, 330-335
107. Sinha, B. K.; Katki, A. G.; Batist, G.; Cowan, K. H.; Myers, C. E. Adriamycin-stimulated hydroxyl radical formation in human breast tumor cells Biochem. Pharmacol. 1987, 36, 793-796
108. Sinha, B. K.; Katki, A. G.; Batist, G.; Cowan, K. H.; Myers, C. E. Differential formation of hydroxyl radicals by adriamycin in sensitive and resistant MCF-7 human breast tumor cells: implications for the mechanism of action Biochemistry 1987, 26, 3776-3781
109. Magee, J. A.; Piskounova, E.; Morrison, S. J. Cancer stem cells: impact, heterogeneity, and uncertainty Cancer Cell 2012, 21, 283-296
110. Visvader, J. E.; Lindeman, G. J. Cancer stem cells: current status and evolving complexities Cell Stem Cell 2012, 10, 717-728
111. Roesch, A.; Fukunaga-Kalabis, M.; Schmidt, E. C.; Zabierowski, S. E.; Brafford, P. A.; Vultur, A.; Basu, D.; Gimotty, P.; Vogt, T.; Herlyn, M. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth Cell 2010, 141, 583-594
112. Williams, R. T.; den Besten, W.; Sherr, C. J. Cytokine-dependent imatinib resistance in mouse BCR-ABL+, Arf-null lymphoblastic leukemia Genes Dev. 2007, 21, 2283-2287
113. Chaffer, C. L.; Brueckmann, I.; Scheel, C.; Kaestli, A. J.; Wiggins, P. A.; Rodrigues, L. O.; Brooks, M.; Reinhardt, F.; Su, Y.; Polyak, K.; Arendt, L. M.; Kuperwasser, C.; Bierie, B.; Weinberg, R. A. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state Proc. Natl. Acad. Sci. U.S.A. 2011, 108, 7950-7955
114. Rowan, K. Are cancer stem cells real? After four decades, debate still simmers J. Natl. Cancer Inst. 2009, 101, 546-547
115. Singh, A.; Settleman, J. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer Oncogene 2010, 29, 4741-4751
116. Lonergan, T.; Brenner, C.; Bavister, B. Differentiation-related changes in mitochondrial properties as indicators of stem cell competence J. Cell. Physiol. 2006, 208, 149-153
117. Schieke, S. M.; Ma, M.; Cao, L.; McCoy, J. P., Jr.; Liu, C.; Hensel, N. F.; Barrett, A. J.; Boehm, M.; Finkel, T. Mitochondrial metabolism modulates differentiation and teratoma formation capacity in mouse embryonic stem cells J. Biol. Chem. 2008, 283, 28506-28512
118. Ye, X. Q.; Li, Q.; Wang, G. H.; Sun, F. F.; Huang, G. J.; Bian, X. W.; Yu, S. C.; Qian, G. S. Mitochondrial and energy metabolism-related properties as novel indicators of lung cancer stem cells Int. J. Cancer 2011, 129, 820-831
119. Greger, V.; Passarge, E.; Hopping, W.; Messmer, E.; Horsthemke, B. Epigenetic changes may contribute to the formation and spontaneous regression of retinoblastoma Hum. Genet. 1989, 83, 155-158
120. Lujambio, A.; Esteller, M. How epigenetics can explain human metastasis: a new role for microRNAs Cell Cycle 2009, 8, 377-382
121. Rodenhiser, D. I. Epigenetic contributions to cancer metastasis Clin. Exp. Metastasis 2009, 26, 5-18
122. Sharma, S.; Kelly, T. K.; Jones, P. A. Epigenetics in cancer Carcinogenesis 2010, 31, 27-36
123. Danson, S.; Ferry, D.; Alakhov, V.; Margison, J.; Kerr, D.; Jowle, D.; Brampton, M.; Halbert, G.; Ranson, M. Phase I dose escalation and pharmacokinetic study of Pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer Br. J. Cancer 2004, 90, 2085-2091
124. Valle, J. W.; Armstrong, A.; Newman, C.; Alakhov, V.; Pietrzynski, G.; Brewer, J.; Campbell, S.; Corrie, P.; Rowinsky, E. K.; Ranson, M. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting Pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction Invest. New Drugs 2011, 29, 1029-1037
125. Chen, Y.; Sha, X.; Zhang, W.; Zhong, W.; Fan, Z.; Ren, Q.; Chen, L.; Fang, X. Pluronic mixed micelles overcoming methotrexate multidrug resistance: in vitro and in vivo evaluation Int. J. Nanomed. 2013, 8, 1463-1476
126. Chen, L.; Sha, X.; Jiang, X.; Chen, Y.; Ren, Q.; Fang, X. Pluronic P105/F127 mixed micelles for the delivery of docetaxel against Taxol-resistant non-small cell lung cancer: optimization and in vitro, in vivo evaluation Int. J. Nanomed. 2013, 8, 73-84
127. Shen, J.; Yin, Q.; Chen, L.; Zhang, Z.; Li, Y. Co-delivery of paclitaxel and survivin shRNA by Pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer Biomaterials 2012, 33, 8613-8624
128. Wang, Y.; Hao, J.; Li, Y.; Zhang, Z.; Sha, X.; Han, L.; Fang, X. Poly(caprolactone)-modified Pluronic P105 micelles for reversal of paclitaxcel-resistance in SKOV-3 tumors Biomaterials 2012, 33, 4741-4751
129. Wang, Y.; Yu, L.; Han, L.; Sha, X.; Fang, X. Difunctional Pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and Pluronic-mediated overcoming multidrug resistance in tumor cell lines Int. J. Pharm. 2007, 337, 63-73
130. Cambon, A.; Rey-Rico, A.; Barbosa, S.; Soltero, J. F.; Yeates, S. G.; Brea, J.; Loza, M. I.; Alvarez-Lorenzo, C.; Concheiro, A.; Taboada, P.; Mosquera, V. Poly(styrene oxide)-poly(ethylene oxide) block copolymers: From "classical" chemotherapeutic nanocarriers to active cell-response inducers J. Controlled Release 2013, 167, 68-75
131. Werle, M. Natural and synthetic polymers as inhibitors of drug efflux pumps Pharm. Res. 2008, 25, 500-511
132. Cambon, A.; Brea, J.; Loza, M. I.; Alvarez-Lorenzo, C.; Concheiro, A.; Barbosa, S.; Taboada, P.; Mosquera, V. Cytocompatibility and P-glycoprotein inhibition of block copolymers: structure-activity relationship Mol. Pharmaceutics 2013, 10, 3232-3241
133. Collnot, E. M.; Baldes, C.; Wempe, M. F.; Hyatt, J.; Navarro, L.; Edgar, K. J.; Schaefer, U. F.; Lehr, C. M. Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers J. Controlled Release 2006, 111, 35-40
134. Lo, Y. L. Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines J. Controlled Release 2003, 90, 37-48